Russia First To Approve COVID-19 Vaccine ‘Sputnik V’ But People Have Questions
6Phase II was started
The Phase II trials were started on July 13. And soon on August 3rd, it was announced that the Gamaleya Institute had completed clinical trials. Something that was not part of the report was whether all the three stages of clinical trials were over, or only stage II was completed. This is because Phase II trials usually take a couple of months.
7According to Russia
According to Russia the Phase III human trials will be completed after the shot received regulatory approval. So, now the Phase III human trials should begin. During this phase, the candidate vaccine will be tested on tens of thousands of people for its effectiveness in real-life situations.
8When will the vaccine be available?
According to Deputy Prime Minister Tatyana Golikova, the vaccine would appear in circulation starting on January 1, 2021. Russia’s health minister also said that “risk groups” that consist of medical workers might be offered the vaccine this month and a mass vaccination program would be launched in October.
9Who will be the first to use it?
According to Russia’s health minister, doctors and teachers would be among the first group who would receive the vaccine. Unfortunately, there is no price decided yet for the vaccine. All this sounds like very positive news but there are still some who have concerns regarding the vaccine.
10What are the concerns?
The concerns that have been raised are due to the superfast speed at which the Russian vaccine has been produced. Many other institutes like the Oxford-AstraZeneca, Moderna, and Pfizer have been left behind who were the front runners at developing the vaccine. This has led many to believe citizens could be at risk.